Lara Meisner's Insider Trades & SAST Disclosures
Lara Meisner's most recent trade in Bicara Therapeutics Inc. was a trade of 79,146 Common Stock done at an average price of $5.5 . Disclosure was reported to the exchange on March 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lara Meisner.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 14 Mar 2025 | 79,146 | 79,145 | - | 5.5 | 431,346 | Common Stock |
| Bicara Therapeutics Inc. | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 48,720 | 107,187 | - | - | Stock Option (Right to Buy) | |
| Bicara Therapeutics Inc. | Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 12.69 per share. | 14 Mar 2025 | 48,526 | 30,620 | - | 12.7 | 615,698 | Common Stock |
| Bicara Therapeutics Inc. | Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 13.24 per share. | 14 Mar 2025 | 30,620 | 0 | - | 13.2 | 405,513 | Common Stock |
| Bicara Therapeutics Inc. | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 30,246 | 67,119 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 15 Jun 2023 | 2,269 | 32,240 (0%) | 0% | 23.0 | 52,255 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 2,269 | 37,481 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 28.02 per share. | 15 Jun 2023 | 2,269 | 29,971 (0%) | 0% | 28.0 | 63,577 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 28 | 37,453 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 28.33 per share. | 15 Jun 2023 | 27 | 29,971 (0%) | 0% | 28.3 | 765 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.04 per share. | 15 Jun 2023 | 27 | 29,998 (0%) | 0% | 23.0 | 622 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.51 per share. | 02 Jun 2023 | 5,126 | 35,097 (0%) | 0% | 18.5 | 94,882 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 5,126 | 84,375 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 02 Jun 2023 | 5,126 | 29,971 (0%) | 0% | 25.0 | 128,253 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 1,875 | 18,128 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 24.21 per share. | 02 Jun 2023 | 1,875 | 29,971 (0%) | 0% | 24.2 | 45,394 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.00 per share. | 02 Jun 2023 | 1,875 | 31,846 (0%) | 0% | 14 | 26,250 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 499 | 89,501 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 02 Jun 2023 | 499 | 29,971 (0%) | 0% | 25.0 | 12,490 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.51 per share. | 02 Jun 2023 | 499 | 30,470 (0%) | 0% | 18.5 | 9,236 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 29.07 per share. | 09 Mar 2023 | 29,971 | 0 (0%) | 0% | 29.1 | 871,257 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 108,000 | 108,000 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 35.66 per share. | 23 Jan 2023 | 6,843 | 0 (0%) | 0% | 35.7 | 244,021 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 23 Jan 2023 | 4,971 | 4,971 (0%) | 0% | 23.0 | 114,482 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2023 | 4,971 | 39,750 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.00 per share. | 23 Jan 2023 | 1,872 | 6,843 (0%) | 0% | 14 | 26,208 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2023 | 1,872 | 20,003 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2022 | 16,326 | 44,721 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 29.19 per share. | 20 Dec 2022 | 16,326 | 0 (0%) | 0% | 29.2 | 476,556 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 20 Dec 2022 | 16,326 | 16,326 (0%) | 0% | 23.0 | 375,988 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 20 Dec 2022 | 600 | 600 (0%) | 0% | 23.0 | 13,818 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2022 | 600 | 61,047 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 28.07 per share. | 20 Dec 2022 | 600 | 0 (0%) | 0% | 28.1 | 16,842 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 28.44 per share. | 15 Dec 2022 | 1,297 | 0 (0%) | 0% | 28.4 | 36,887 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 1,297 | 61,647 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 15 Dec 2022 | 1,297 | 1,297 (0%) | 0% | 23.0 | 29,870 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 300 | 62,944 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 28.08 per share. | 15 Dec 2022 | 300 | 0 (0%) | 0% | 28.1 | 8,424 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 15 Dec 2022 | 300 | 300 (0%) | 0% | 23.0 | 6,909 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 15,656 | 63,244 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 28.12 per share. | 12 Dec 2022 | 15,656 | 0 (0%) | 0% | 28.1 | 440,247 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 12 Dec 2022 | 15,656 | 15,656 (0%) | 0% | 23.0 | 360,558 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 28.05 per share. | 12 Dec 2022 | 600 | 0 (0%) | 0% | 28.1 | 16,830 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 600 | 78,900 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 12 Dec 2022 | 600 | 600 (0%) | 0% | 23.0 | 13,818 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 22.05 per share. | 15 Nov 2022 | 8,125 | 0 (0%) | 0% | 22.0 | 179,156 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.00 per share. | 15 Nov 2022 | 8,125 | 8,125 (0%) | 0% | 14 | 113,750 | Common Stock |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 8,125 | 21,875 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Lara Meisner | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges